EnsoData acquires sleep testing diagnostic technology from Resonea to enhance sleep apnea screening capabilities
Jul 10, 2024•over 1 year ago
Acquiring Company
EnsoData
Acquired Company
Resonea
Description
EnsoData has completed the acquisition of sleep testing diagnostic technology from Resonea to improve access and affordability in underserved patient populations. With this acquisition, EnsoData expands its diagnostic capabilities for sleep apnea and aims to reduce the cost of systematically addressing sleep apnea across large patient populations.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed